2781. Statistical Modeling to Predict Maternal RSV Vaccine Efficacy from Neutralizing Titers

BACKGROUND: In the United States, respiratory syncytial virus (RSV) is the leading cause of respiratory-related hospitalization in infants. The well-studied efficacy of the prophylactic monoclonal antibody, palivizumab, at preventing RSV disease in the highest risk infants provides proof of mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Bing, Chen, Yili, Agosti, Yasmeen, Swanson, Kena, Schmoele-Thoma, Beate, Jansen, Kathrin U, Gruber, William C, Koury, Kenneth, Dormitzer, Philip R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810036/
http://dx.doi.org/10.1093/ofid/ofz360.2458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810036/
http://dx.doi.org/10.1093/ofid/ofz360.2458

Ejemplares similares